168 related articles for article (PubMed ID: 16699289)
1. Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an experimental nephrotic syndrome model.
Yilmaz MI; Korkmaz A; Kaya A; Sonmez A; Caglar K; Topal T; Eyileten T; Yenicesu M; Acikel C; Oter S; Yaman H; Aktug H; Oguz Y; Vural A; Ikizler TA
Nephron Exp Nephrol; 2006; 104(1):e15-22. PubMed ID: 16699289
[TBL] [Abstract][Full Text] [Related]
2. Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model.
Sonmez A; Yilmaz MI; Korkmaz A; Topal T; Caglar K; Kaya A; Eyileten T; Yenicesu M; Oguz Y; Basal S; Ipcioglu OM; Vural A
Clin Exp Nephrol; 2008 Apr; 12(2):110-118. PubMed ID: 18175058
[TBL] [Abstract][Full Text] [Related]
3. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of exogenously administered or endogenously produced melatonin on hyperbaric oxygen-induced oxidative stress in the rat brain.
Dundar K; Topal T; Ay H; Oter S; Korkmaz A
Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):926-30. PubMed ID: 16405448
[TBL] [Abstract][Full Text] [Related]
5. Hyperbaric oxygen therapy alleviates oxidative stress and tissue injury in renal ischemia/reperfusion injury in rats.
Ilhan H; Eroglu M; Inal V; Eyi YE; Arziman I; Yildirim AO; Tansel A; Uzun G; Yamanel L
Ren Fail; 2012; 34(10):1305-8. PubMed ID: 23009323
[TBL] [Abstract][Full Text] [Related]
6. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
[TBL] [Abstract][Full Text] [Related]
7. Preconditioning with hyperbaric oxygen induces tolerance against renal ischemia-reperfusion injury via increased expression of heme oxygenase-1.
He X; Xu X; Fan M; Chen X; Sun X; Luo G; Chen L; Mu Q; Feng Y; Mao Q; Chao Z
J Surg Res; 2011 Oct; 170(2):e271-7. PubMed ID: 21816440
[TBL] [Abstract][Full Text] [Related]
8. Effect of preconditioned hyperbaric oxygen and ozone on ischemia-reperfusion induced tourniquet in skeletal bone of rats.
Koca K; Yurttas Y; Bilgic S; Cayci T; Topal T; Durusu M; Kaldirim U; Akgul EO; Ozkan H; Yanmis I; Oguz E; Tunay S; Korkmaz A; Basbozkurt M
J Surg Res; 2010 Nov; 164(1):e83-9. PubMed ID: 20850777
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant effects of melatonin in rats during chronic exposure to hyperbaric oxygen.
Mollaoglu H; Topal T; Ozler M; Uysal B; Reiter RJ; Korkmaz A; Oter S
J Pineal Res; 2007 Jan; 42(1):50-4. PubMed ID: 17198538
[TBL] [Abstract][Full Text] [Related]
10. ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats.
Zima T; Tesar V; Crkovská J; Stejskalová A; Pláteník J; Temínová J; Nemecek K; Janebová M; Stípek S
Nephrol Dial Transplant; 1998 Aug; 13(8):1975-9. PubMed ID: 9719150
[TBL] [Abstract][Full Text] [Related]
11. [Relativity of nuclear factor-kappaB (P65/Rel-A) and angiotensin II type 1 receptor expression in early stage of lesions of adriamycin nephrosis in young rats and the effects of intervention].
Ma H; Li Z; Meng QH; Li XH; Wang XH; Li H; Li WW
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):275-9. PubMed ID: 15157388
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Hyperbaric Oxygen Treatment on Total Antioxidant Capacity and Prolidase Activity after Bile Duct Ligation in Rats.
Terzioglu D; Uslu L; Simsek G; Atukeren P; Erman H; Gelisgen R; Ayvaz S; Aksu B; Uzun H
J Invest Surg; 2017 Dec; 30(6):376-382. PubMed ID: 27922759
[TBL] [Abstract][Full Text] [Related]
13. Effects of different doses of hyperbaric oxygen on cisplatin-induced nephrotoxicity.
Aydinoz S; Uzun G; Cermik H; Atasoyu EM; Yildiz S; Karagoz B; Evrenkaya R
Ren Fail; 2007; 29(3):257-63. PubMed ID: 17497437
[TBL] [Abstract][Full Text] [Related]
14. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Fukuda A; Fujimoto S; Iwatsubo S; Kawachi H; Kitamura K
Nephrology (Carlton); 2010 Apr; 15(3):321-6. PubMed ID: 20470301
[TBL] [Abstract][Full Text] [Related]
15. Long-term exposure to repetitive hyperbaric oxygen results in cumulative oxidative stress in rat lung tissue.
Simsek K; Ay H; Topal T; Ozler M; Uysal B; Ucar E; Acikel CH; Yesilyurt O; Korkmaz A; Oter S; Yildiz S
Inhal Toxicol; 2011 Feb; 23(3):166-72. PubMed ID: 21391785
[TBL] [Abstract][Full Text] [Related]
16. The effects of hyperbaric oxygen application against cholestatic oxidative stress and hepatic damage after bile duct ligation in rats.
Ayvaz S; Kanter M; Aksu B; Sahin SH; Uzun H; Erboga M; Pul M
J Surg Res; 2013 Jul; 183(1):146-55. PubMed ID: 23462455
[TBL] [Abstract][Full Text] [Related]
17. Increased Efficacy of Antivenom Combined with Hyperbaric Oxygen on
Li M; Xie ZH; Yu AY; He DP
Chin Med J (Engl); 2018 Feb; 131(3):323-329. PubMed ID: 29363648
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Gambier Extract (Uncaria Gambier Robx) and Angiotensin Receptor Blocker on Proteinuria Reduction and Antioxidants - Enhancement in Nephrotic Rat Models.
Siregar RS; Ramayani OR; Haris D; Lelo A; Jusuf NK; Eyanoer PC; Rusda M; Amin MM
Med Arch; 2023; 77(6):422-427. PubMed ID: 38313113
[TBL] [Abstract][Full Text] [Related]
19. Hyperbaric oxygen therapy induces kidney protection in an ischemia/reperfusion model in rats.
Ramalho RJ; de Oliveira PS; Cavaglieri RC; Silva C; Medeiros PR; Filho DM; Poli-de-Figueiredo LF; Noronha IL
Transplant Proc; 2012 Oct; 44(8):2333-6. PubMed ID: 23026586
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome.
Bulucu F; Oktenli C; Kenar L; Ocal R; Koc B; Inal V; Yamanel L; Yaman H; Sanisoglu YS; Aydin A
J Nephrol; 2008; 21(4):576-83. PubMed ID: 18651549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
